DNAprint Genomics (DNAG)

[mjam]

I'd be interested to see some of the esteemed researchers on our boards figure out which of the start up / medium sized drug companies might have new drugs or re-engineered drugs already as far along as phase II clinical trials that could benefit from DNAP's science. I don't believe there are more than a dozen. Only 4 or 5 that would be candidates for "involvement" with DNAP. Becoming a drug company within a year takes a pretty bold move and it certainly doesn't involve starting from scratch. We have the resources to make this happen.

How 'bout it, ming? re-engineered Taxol might be a start...